These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 17935949

  • 1. Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators.
    Giamarellos-Bourboulis EJ.
    Int J Antimicrob Agents; 2008 Jan; 31(1):12-20. PubMed ID: 17935949
    [Abstract] [Full Text] [Related]

  • 2. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
    Amsden GW.
    J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
    [Abstract] [Full Text] [Related]

  • 3. [Usefulness of macrolides as anti-inflammatories in respiratory diseases].
    Sevilla-Sánchez D, Soy-Muner D, Soler-Porcar N.
    Arch Bronconeumol; 2010 May; 46(5):244-54. PubMed ID: 19962815
    [Abstract] [Full Text] [Related]

  • 4. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases.
    López-Boado YS, Rubin BK.
    Curr Opin Pharmacol; 2008 Jun; 8(3):286-91. PubMed ID: 18339582
    [Abstract] [Full Text] [Related]

  • 5. Macrolides and airway inflammation in children.
    Shinkai M, Rubin BK.
    Paediatr Respir Rev; 2005 Sep; 6(3):227-35. PubMed ID: 16153572
    [Abstract] [Full Text] [Related]

  • 6. Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?
    King P.
    Drugs; 2007 Sep; 67(7):965-74. PubMed ID: 17488142
    [Abstract] [Full Text] [Related]

  • 7. Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments.
    Cameron EJ, McSharry C, Chaudhuri R, Farrow S, Thomson NC.
    Clin Exp Allergy; 2012 Sep; 42(9):1302-12. PubMed ID: 22925316
    [Abstract] [Full Text] [Related]

  • 8. Clinical implications of the immunomodulatory effects of macrolides.
    Tamaoki J, Kadota J, Takizawa H.
    Am J Med; 2004 Nov 08; 117 Suppl 9A():5S-11S. PubMed ID: 15586558
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Macrolides as biological response modifiers in cystic fibrosis and bronchiectasis.
    Bush A, Rubin BK.
    Semin Respir Crit Care Med; 2003 Dec 08; 24(6):737-48. PubMed ID: 16088589
    [Abstract] [Full Text] [Related]

  • 11. Anti-inflammatory effects of macrolides: applications in chronic rhinosinusitis.
    Harvey RJ, Wallwork BD, Lund VJ.
    Immunol Allergy Clin North Am; 2009 Nov 08; 29(4):689-703. PubMed ID: 19879444
    [Abstract] [Full Text] [Related]

  • 12. Long-term macrolide treatment for chronic respiratory disease.
    Spagnolo P, Fabbri LM, Bush A.
    Eur Respir J; 2013 Jul 08; 42(1):239-51. PubMed ID: 23180583
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Macrolide therapy of chronic rhinosinusitis.
    Cervin A, Wallwork B.
    Rhinology; 2007 Dec 08; 45(4):259-67. PubMed ID: 18085018
    [Abstract] [Full Text] [Related]

  • 19. Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action.
    Shinkai M, Henke MO, Rubin BK.
    Pharmacol Ther; 2008 Mar 08; 117(3):393-405. PubMed ID: 18289694
    [Abstract] [Full Text] [Related]

  • 20. [Immunomodulatory properties of macrolides].
    Targowski T, Jahnz-Rózyk K.
    Pol Merkur Lekarski; 2008 Nov 08; 25(149):408-11. PubMed ID: 19177776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.